Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | TABLET;ORAL | EQ 10MG BASE | 0 | PAROXETINE | PAROXETINE HYDROCHLORIDE |
002 | TABLET;ORAL | EQ 20MG BASE | 0 | PAROXETINE | PAROXETINE HYDROCHLORIDE |
003 | TABLET;ORAL | EQ 30MG BASE | 0 | PAROXETINE | PAROXETINE HYDROCHLORIDE |
004 | TABLET;ORAL | EQ 40MG BASE | 0 | PAROXETINE | PAROXETINE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2014-10-31 | |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
PRINSTON INC
cder:Array
(
[0] => Array
(
[ApplNo] => 203854
[companyName] => PRINSTON INC
[docInserts] => ["",""]
[products] => [{"drugName":"PAROXETINE","activeIngredients":"PAROXETINE HYDROCHLORIDE","strength":"EQ 10MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PAROXETINE","activeIngredients":"PAROXETINE HYDROCHLORIDE","strength":"EQ 20MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PAROXETINE","activeIngredients":"PAROXETINE HYDROCHLORIDE","strength":"EQ 30MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"PAROXETINE","activeIngredients":"PAROXETINE HYDROCHLORIDE","strength":"EQ 40MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"10\/31\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] => [{"actionDate":"04\/29\/2020","submission":"SUPPL-1","supplementCategories":"Labeling-Container\/Carton Labels, Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
[actionDate] => 2020-04-29
)
)